CORXEL Pharmaceuticals

Drug Discovery · Shanghai, China · Founded 2019 · Privately Held (backing)

Developer of small molecule cardiac myosin inhibitor drug treatments designed for the treatment of hypertrophic cardiomyopathy, in-licensed from Cytokinetics. CORXEL Pharmaceuticals is based in Shanghai, China and was founded in 2019. Its last reported valuation was $475 million in Sep 2024. It has raised $452 million across 1 recorded round; the latest was a $287 million Series D1 in Jan 2026.

Last reported valuation
$474.9M
Oct 2026
Priced at
—
Total raised
$451.8M
Last round
Later Stage VC (Series D1)
Jan 2026
How much has CORXEL Pharmaceuticals raised?
$451.8Macross 1 recorded rounds · Jan 2026 – Jan 2026

Most recently, CORXEL Pharmaceuticals raised $287.0M in its Later Stage VC (Series D1) (Jan 2026).

Free account
More of CORXEL Pharmaceuticals with a free account
  • ·The complete investor list: 13 names
  • ·Watch CORXEL Pharmaceuticals: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

CORXEL Pharmaceuticals round by round

1 rounds
Jan 2026Later Stage VC (Series D1)$287.0M▮
+ 1 more investors · free account

How much has CORXEL Pharmaceuticals raised?

CORXEL Pharmaceuticals has raised $452 million in total; 1 of its rounds is on record. The largest on record was a $287 million Series D1 in Jan 2026.

CORXEL Pharmaceuticals investors

13 investors are on record for CORXEL Pharmaceuticals, including RA Capital Management, New Enterprise Associates, The Invus Group and SR One Capital Management. By type, the record holds 3 hedge funds, 1 venture capital firm and 1 asset manager. The Series D1 in Jan 2026 drew 9 investors.

For fundraisers
Raising for a company like CORXEL Pharmaceuticals?

13 investors have backed CORXEL Pharmaceuticals — start your target list with the firms already writing checks in drug discovery.

See all 13 investors →

Frequently asked about CORXEL Pharmaceuticals

How much has CORXEL Pharmaceuticals raised?
CORXEL Pharmaceuticals has raised $451.8M in total across 1 recorded funding rounds.
When was CORXEL Pharmaceuticals's last funding round?
CORXEL Pharmaceuticals's most recent recorded round was Later Stage VC (Series D1) in Jan 2026, raising $287.0M.